Living Mirrors with Dr. James Cooke
Amanda Feilding on psychedelic research | Living Mirrors #53
Jun 2, 2021
Amanda Feilding, a trailblazing drug policy reformer and founder of the Beckley Foundation, dives deep into the transformative world of psychedelics. She shares fascinating insights from her early experiences with LSD, highlighting its role in understanding consciousness. The conversation explores the stigma surrounding psychedelics and their therapeutic potential, discussing groundbreaking research like psilocybin trials for depression. Amanda emphasizes the urgent need for intelligent drug policy reform and increased accessibility to psychedelic therapies in the face of a mental health crisis.
01:19:44
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Amanda Feilding emphasizes the need for decriminalization and responsible use of psychedelics to reshape societal and therapeutic approaches.
- The Beckley Foundation has played a crucial role in groundbreaking psychedelic research, including studies on psilocybin and LSD for mental health treatment.
Deep dives
Early Influences and Mystical Experiences
Amanda Fielding's fascination with altered states of consciousness began early in her life, influenced by her isolated upbringing and spiritual background. She had a strong connection to mystical experiences, emphasizing a relationship with a god figure during childhood and exposure to various religious philosophies through her family. Fielding's journey led her to study under prominent figures in comparative religions, which solidified her passion for understanding consciousness. Her first experience with LSD in 1965 revealed to her a profound connection to these mystical experiences, emphasizing the significance of psychedelics in exploring human consciousness.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
